Literature DB >> 25450502

Site-specific structural characterization of O-glycosylation and identification of phosphorylation sites of recombinant osteopontin.

Hong Li1, Huali Shen2, Guoquan Yan1, Yang Zhang2, Mingqi Liu1, Pan Fang1, Hongxiu Yu3, Pengyuan Yang4.   

Abstract

Osteopontin (OPN) plays a key role in multiple physiological and pathological processes such as cytokine production, mineralization, inflammation, immune responses, and tumorigenesis. Post-translational modifications (PTMs) of OPN significantly affect its structure and biological properties; however, site-specific characterization of O-glycosylation in human OPN has not been reported. In this work, we profiled the overall glycan pattern of human recombinant OPN using a lectin array and completed detailed structural analysis of O-glycopeptides by mass spectrometry (MS). We detected 28 O-glycopeptides from 7 O-glycosylation regions of human OPN, occupied by highly heterogeneous O-glycans. These O-glycans carried, in part, functionally relevant epitopes such as T antigens (Galβ1-3GalNAcα1-), sialyl-Tn antigens, sialyl-T antigens, and sialyl-Le(x/a) antigens [Neuα2-3Galβ1-4(Fucα1-3)GlcNAc/Neuα2-3Galβ1-3(Fucα1-4)GlcNAc]. MS(3) spectra of the generated O-glycopeptides showed cleavages of the peptide backbone and provided essential information on the peptide sequence. Furthermore, 26 phosphorylation sites were identified by reverse-phase liquid chromatography-tandem mass spectrometry (RPLC-MS/MS), including a novel one (Y209). We provide a detailed, site-specific structural characterization of O-glycosylation and identify the phosphorylation sites of OPN. These data lay the foundation for further research into the role of oligosaccharides and phosphorylation of recombinant human OPN. This article is part of a Special Issue entitled: Medical Proteomics.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Mass spectrometry; O-glycosylation; Osteopontin; Phosphorylation; Site-specific

Mesh:

Substances:

Year:  2014        PMID: 25450502     DOI: 10.1016/j.bbapap.2014.09.025

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Intranasal Delivery of RGD Motif-Containing Osteopontin Icosamer Confers Neuroprotection in the Postischemic Brain via αvβ3 Integrin Binding.

Authors:  Yin-Chuan Jin; Hahnbie Lee; Seung-Woo Kim; Il-Doo Kim; Hye-Kyung Lee; Yunjin Lee; Pyung-Lim Han; Ja-Kyeong Lee
Journal:  Mol Neurobiol       Date:  2015-10-19       Impact factor: 5.590

2.  Recombinant human osteopontin expressed in Nicotiana benthamiana stimulates osteogenesis related genes in human periodontal ligament cells.

Authors:  Kaewta Rattanapisit; Supaniga Abdulheem; Daneeya Chaikeawkaew; Anchanee Kubera; Hugh S Mason; Julian K-C Ma; Prasit Pavasant; Waranyoo Phoolcharoen
Journal:  Sci Rep       Date:  2017-12-11       Impact factor: 4.379

Review 3.  Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.

Authors:  Nausicaa Clemente; Davide Raineri; Giuseppe Cappellano; Elena Boggio; Francesco Favero; Maria Felicia Soluri; Chiara Dianzani; Cristoforo Comi; Umberto Dianzani; Annalisa Chiocchetti
Journal:  J Immunol Res       Date:  2016-12-20       Impact factor: 4.818

4.  An antibody-free sample pretreatment method for osteopontin combined with MALDI-TOF MS/MS analysis.

Authors:  Yuye Zhou; Joakim Romson; Åsa Emmer
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

5.  Osteopontin isoforms differentially promote arteriogenesis in response to ischemia via macrophage accumulation and survival.

Authors:  Grace Sanghee Lee; Hector F Salazar; Giji Joseph; Zoe Shin Yee Lok; Courtney M Caroti; Daiana Weiss; W Robert Taylor; Alicia N Lyle
Journal:  Lab Invest       Date:  2018-06-29       Impact factor: 5.662

Review 6.  Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight.

Authors:  Anne-Sophie Lamort; Ioanna Giopanou; Ioannis Psallidas; Georgios T Stathopoulos
Journal:  Cells       Date:  2019-08-02       Impact factor: 6.600

7.  Phosphorylated Osteopontin Secreted from Cancer Cells Induces Cancer Cell Motility.

Authors:  Yoshinobu Kariya; Midori Oyama; Yukiko Kariya; Yasuhiro Hashimoto
Journal:  Biomolecules       Date:  2021-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.